用机器学习驱动的网络方法揭示急性髓细胞和淋巴细胞白血病的低维miR-based特征
Uncovering low-dimensional, miR-based signatures of acute myeloid and lymphoblastic leukemias with a machine-learning-driven network approach
摘要:
不同急性白血病之间复杂的表型差异不能通过一次分析一个单一分子(如miR)的表达水平来完全捕获,而是需要对大量miR进行系统分析。虽然用于分析此类数据集的流行方法是主成分分析(PCA),但该方法并不是设计用于最佳区分不同表型。此外,PCA和其他低维表示方法产生所有测量的miR的线性或非线性组合。在AML、B-ALL和T-ALL细胞系和患者RNA样品中测量了总体人miR表达。通过系统地将支持向量机应用于在二分体和三分体组中采集的所有测量的miR,我们使用细胞系数据构建了miR网络,并使用主要患者样本验证了我们的发现。已知作为急性白血病的肿瘤抑制因子的miR-23 a簇的所有协同转录成员(还包括miR-24和miR-27 a)出现在AML、B-ALL和T-ALL中心网络中。随后的qRT-PCR分析显示,B-ALL中心网络中最相关的miR-708在B-ALL中高度特异性表达,表明miR-708可能作为B-ALL的生物标志物。这种方法是系统的、定量的、可扩展的和无偏见的。我们的方法产生的不是单个签名,而是一个签名网络,反映了生物信号通路的冗余性质。网络表示允许专家对所有签名进行视觉分析,并允许将来整合其他信息。此外,每个签名仅涉及小的miR集合,例如二联体和三联体,其非常适合通过实验室实验进行深入验证,例如设计用于驱动白血病细胞存活、增殖和分化的变化的功能丧失和获得测定。
英文摘要:
Complex phenotypic differences among different acute leukemias cannot be fully captured by analyzing the expression levels of one single molecule, such as a miR, at a time, but requires systematic analysis of large sets of miRs. While a popular approach for analysis of such datasets is principal component analysis (PCA), this method is not designed to optimally discriminate different phenotypes. Moreover, PCA and other low-dimensional representation methods yield linear or non-linear combinations of all measured miRs. Global human miR expression was measured in AML, B-ALL, and T-ALL cell lines and patient RNA samples. By systematically applying support vector machines to all measured miRs taken in dyad and triad groups, we built miR networks using cell line data and validated our findings with primary patient samples. All the coordinately transcribed members of the miR-23a cluster (which includes also miR-24 and miR-27a), known to function as tumor suppressors of acute leukemias, appeared in the AML, B-ALL and T-ALL centric networks. Subsequent qRT-PCR analysis showed that the most connected miR in the B-ALL-centric network, miR-708, is highly and specifically expressed in B-ALLs, suggesting that miR-708 might serve as a biomarker for B-ALL. This approach is systematic, quantitative, scalable, and unbiased. Rather than a single signature, our approach yields a network of signatures reflecting the redundant nature of biological signaling pathways. The network representation allows for visual analysis of all signatures by an expert and for future integration of additional information. Furthermore, each signature involves only small sets of miRs, such as dyads and triads, which are well suited for in depth validation through laboratory experiments such as loss- and gain-of-function assays designed to drive changes in leukemia cell survival, proliferation and differentiation.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。